Nu Skin Enterprises (NUS) has been struggling in recent months, experiencing a decline in its share price and revenue. The company has been impacted by macroeconomic headwinds, foreign currency fluctuations, and pressures within the direct selling industry. As a result, Nu Skin has tightened its annual guidance for 2024, indicating a difficult road ahead. Investors should remain cautious and monitor the company’s efforts to navigate these challenges.